JAMP LAMIVUDINE
Identification of Jamp Lamivudine
| No description |
Google image searchProduct monograph
Active ingredient
lamivudine, 300 MG
DIN: 02507129
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: JAMP PHARMA CORPORATION
Date: 16-MAR-2021
ATC:
- J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
- J05AF — Nucleoside and nucleotide reverse transcriptase inhibitors (ATC, ATC/DDD)
- J05AF05 — LAMIVUDINE (ATC/DDD)
Reference brand drug: 3tc, Heptovir
Pharmaceutical standard: USP
